Penumbra (DE:0P8)

Penumbra Stock Analysis & Ratings



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Penumbra’s price range in the past 12 months?
Currently, no data Available
What is Penumbra’s market cap?
Currently, no data Available
What is Penumbra’s price target?
The average price target for Penumbra is €190.01. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is €216.22 ,the lowest forecast is €160.20. The average price target represents 16.57% Increase from the current price of €163.
    What do analysts say about Penumbra?
    Penumbra’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
      When is Penumbra’s upcoming earnings report date?
      Penumbra’s upcoming earnings report date is Nov 09, 2022 which is in 93 days.
        How were Penumbra’s earnings last quarter?
        Penumbra released its earnings results on Aug 04, 2022. The company reported €0.01 earnings per share for the quarter, beating the consensus estimate of -€0.03 by €0.04.
          Is Penumbra overvalued?
          According to Wall Street analysts Penumbra’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Penumbra pay dividends?
            Penumbra does not currently pay dividends.
            What is Penumbra’s EPS estimate?
            Penumbra’s EPS estimate is €0.02.
              How many shares outstanding does Penumbra have?
              Currently, no data Available
              What happened to Penumbra’s price movement after its last earnings report?
              Penumbra reported an EPS of €0.01 in its last earnings report, beating expectations of -€0.03. Following the earnings report the stock price went up 17.266%.
                Which hedge fund is a major shareholder of Penumbra?
                Among the largest hedge funds holding Penumbra’s share is Perceptive Advisors LLC. It holds Penumbra’s shares valued at 32M.


                  Penumbra Stock Analysis

                  Smart Score
                  Price Target
                  ▲(16.57% Upside)
                  Strong Buy
                  The Penumbra Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

                  Similar Stocks
                  Price & Change
                  Abbott Labs
                  Intuitive Surgical
                  Becton Dickinson
                  Edwards Lifesciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis